Tenaya Therapeutics Tech Stack

Tenaya Therapeutics uses 8 technology products and services including Gladstone, NetSuite, web-vitals, and more. Explore Tenaya Therapeutics's tech stack below.

  • Gladstone
    Association Management
  • NetSuite
    E-commerce
  • web-vitals
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Coupa
    Travel And Expense Management
  • Animate.css
    UI Frameworks
  • Drupal Multisite
    Web Hosting

Media & News

Tenaya Therapeutics's Email Address Formats

Tenaya Therapeutics uses at least 5 format(s):
Tenaya Therapeutics Email FormatsExamplePercentage
flast@tenayathera.comJDoe@tenayathera.com
33%
fl@tenayathera.comJD@tenayathera.com
17%
first@tenayathera.comJohn@tenayathera.com
17%
fmiddlelast@tenayathera.comJMichaelDoe@tenayathera.com
16%
last@tenayathera.comDoe@tenayathera.com
17%

Frequently Asked Questions

Where is Tenaya Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Tenaya Therapeutics's main headquarters is located at 171 Oyster Point Blvd South San Francisco, California 94080 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Tenaya Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Tenaya Therapeutics's main corporate office by phone at +1-650-741-9782. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Tenaya Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Tenaya Therapeutics is a publicly traded company; the company's stock symbol is TNYA.

What is Tenaya Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Tenaya Therapeutics's official website is tenayatherapeutics.com and has social profiles on LinkedIn.

How much revenue does Tenaya Therapeutics generate?

Minus sign iconPlus sign icon
As of January 2024, Tenaya Therapeutics's annual revenue reached $35M.

What is Tenaya Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Tenaya Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tenaya Therapeutics have currently?

Minus sign iconPlus sign icon
As of January 2024, Tenaya Therapeutics has approximately 155 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: F. A.Chief Financial And Business Officer: L. P.Chief Technology Officer: K. K.. Explore Tenaya Therapeutics's employee directory with LeadIQ.

What industry does Tenaya Therapeutics belong to?

Minus sign iconPlus sign icon
Tenaya Therapeutics operates in the Biotechnology Research industry.

What technology does Tenaya Therapeutics use?

Minus sign iconPlus sign icon
Tenaya Therapeutics's tech stack includes GladstoneNetSuiteweb-vitalsModernizrWebpackCoupaAnimate.cssDrupal Multisite.

What is Tenaya Therapeutics's email format?

Minus sign iconPlus sign icon
Tenaya Therapeutics's email format typically follows the pattern of flast@tenayathera.com. Find more Tenaya Therapeutics email formats with LeadIQ.

How much funding has Tenaya Therapeutics raised to date?

Minus sign iconPlus sign icon
As of January 2024, Tenaya Therapeutics has raised $340M in funding. The last funding round occurred on Mar 01, 2021 for $106M.

When was Tenaya Therapeutics founded?

Minus sign iconPlus sign icon
Tenaya Therapeutics was founded in 2016.
Tenaya Therapeutics

Tenaya Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Tenaya Therapeutics is a clinical stage biotechnology company. The Company was founded in 2016 by leading cardiovascular scientists from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center.

We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease. Our vision is to change the treatment paradigm for heart disease, and in doing so improve and extend the lives of millions of individuals and families fighting this debilitating disease. We are advancing a pipeline of disease-modifying therapies developed using our product platforms and core internal capabilities to target defined sub-populations of patients with rare or highly prevalent forms of heart disease.

Section iconCompany Overview

Headquarters
171 Oyster Point Blvd South San Francisco, California 94080 US
Phone number
+1-650-741-9782
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TNYA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $340M

    Tenaya Therapeutics has raised a total of $340M of funding over 3 rounds. Their latest funding round was raised on Mar 01, 2021 in the amount of $106Mas a Series C.

  • $10M$50M

    Tenaya Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $340M

    Tenaya Therapeutics has raised a total of $340M of funding over 3 rounds. Their latest funding round was raised on Mar 01, 2021 in the amount of $106Mas a Series C.

  • $10M$50M

    Tenaya Therapeutics's revenue is in the range of $10M$50M

© LeadIQ, Inc. All rights reserved.